» Articles » PMID: 20658835

A Randomized Controlled Trial of Emotionally Expressive Writing for Women with Metastatic Breast Cancer

Overview
Journal Health Psychol
Specialty Public Health
Date 2010 Jul 28
PMID 20658835
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To test the effects of emotionally expressive writing in a randomized controlled trial of metastatic breast cancer patients and to determine whether effects of the intervention varied as a function of perceived social support or time since metastatic diagnosis.

Design: Women (N = 62) living with Stage IV breast cancer were randomly assigned to write about cancer-related emotions (EMO; n = 31) or the facts of their diagnosis and treatment (CTL; n = 31). Participants wrote at home for four 20-min sessions within a 3-week interval.

Main Outcome Measures: Depressive symptoms, cancer-related intrusive thoughts, somatic symptoms, and sleep quality at 3 months postintervention.

Results: No significant main effects of experimental condition were observed. A significant condition x social support interaction emerged on intrusive thoughts; EMO writing was associated with reduced intrusive thoughts for women reporting low emotional support (eta2 = .15). Significant condition x time since metastatic diagnosis interactions were also observed for somatic symptoms and sleep disturbances. Relative to CTL, EMO participants who were more recently diagnosed had fewer somatic symptoms (eta2 = .10), whereas EMO participants with longer diagnosis duration exhibited increases in sleep disturbances (eta2 = .09).

Conclusion: Although there was no main effect of expressive writing on health among the current metastatic breast cancer sample, expressive writing may be beneficial for a subset of metastatic patients (including women with low levels of emotional support or who have been recently diagnosed) and contraindicated for others (i.e., those who have been living with the diagnosis for years).

Citing Articles

Writing between the lines: A secondary analysis of unsolicited narratives from cancer survivors regarding their fear of cancer recurrence.

Galica J, Saunders S, Haase K, Maheu C Can Oncol Nurs J. 2024; 31(1):83-91.

PMID: 38919459 PMC: 11195568. DOI: 10.5737/236880763118391.


.

Galica J, Saunders S, Haase K, Maheu C Can Oncol Nurs J. 2024; 31(1):92-101.

PMID: 38919454 PMC: 11195567. DOI: 10.5737/2368807631192101.


Systematic review and meta-analysis of the effectiveness of expressive writing disclosure on cancer and palliative care patients' health-related outcomes.

Abu-Odah H, Su J, Wang M, Sheffield D, Molassiotis A Support Care Cancer. 2023; 32(1):70.

PMID: 38157056 DOI: 10.1007/s00520-023-08255-8.


Hematopoietic Cell Transplantation Patient-Caregiver Dyad Perspectives on Participation in a Digital Storytelling Intervention: A Qualitative Approach.

Kim S, Langer S, Ahern M, Larkey L, Todd M, Martin D Transplant Cell Ther. 2023; 29(8):520.e1-520.e7.

PMID: 37137443 PMC: 10526713. DOI: 10.1016/j.jtct.2023.04.021.


Cancer and aging: Reflections for elders- Expressive writing intervention: A pilot study.

Tutino R, Saracino R, Kelman J, Schofield E, Roth A, Nelson C J Geriatr Oncol. 2022; 13(5):706-714.

PMID: 35246404 PMC: 10108097. DOI: 10.1016/j.jgo.2022.02.009.


References
1.
Luoma M, Hakamies-Blomqvist L . The meaning of quality of life in patients being treated for advanced breast cancer: a qualitative study. Psychooncology. 2004; 13(10):729-39. DOI: 10.1002/pon.788. View

2.
Goodwin P, Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H . The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001; 345(24):1719-26. DOI: 10.1056/NEJMoa011871. View

3.
Smyth J . Written emotional expression: effect sizes, outcome types, and moderating variables. J Consult Clin Psychol. 1998; 66(1):174-84. DOI: 10.1037//0022-006x.66.1.174. View

4.
Kissane D, Grabsch B, Clarke D, Smith G, Love A, Bloch S . Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psychooncology. 2007; 16(4):277-86. DOI: 10.1002/pon.1185. View

5.
Horowitz M, WILNER N, Alvarez W . Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979; 41(3):209-18. DOI: 10.1097/00006842-197905000-00004. View